1140503-26-9Relevant academic research and scientific papers
Discovery of 6-({4-[2-(4-tert-Butylphenyl)-1H-benzimidazol-4-yl]piperazin- 1-yl}methyl)quinoxaline(WAY-207024): An orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)
Pelletier, Jeffrey C.,Chengalvala, Murty V.,Cottom, Joshua E.,Feingold, Irene B.,Green, Daniel M.,Hauze, Diane B.,Huselton, Christine A.,Jetter, James W.,Kopf, Gregory S.,Lundquist, Joseph T.,Magolda, Ronald L.,Mann, Charles W.,Mehlmann, John F.,Rogers, John F.,Shanno, Linda K.,Adams, William R.,Tio, Cesario O.,Wrobel, Jay E.
, p. 2148 - 2152 (2009)
A potent, highly insoluble, GnRH antagonist with a 2-phenyl-4- piperazinylbenzimidazole template and a quinoxaline-2,3-dione pharmacophore was modified to maintain GnRH antagonist activity and improve in vitro pharmaceutical properties. Structural changes
